Endurant Capital Management LP Sanofi Transaction History

Endurant Capital Management LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $20.6 Million - $22.8 Million	-424,490 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $17.4 Million - $19.4 Million	369,669 Added 674.32%	424,490 $21.3 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $2.63 Million - $2.91 Million	54,821 New	54,821 $2.64 Million
Q2 2021 Aug 16, 2021	SELL	$49.36 - $54.25 $13.4 Million - $14.8 Million	-272,218 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $12.4 Million - $13.7 Million	272,218 New	272,218 $13.5 Million
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $4.94 Million - $5.37 Million	-99,869 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.91 - $52.5 $13.3 Million - $16.3 Million	-310,092 Reduced 75.64%	99,869 $5.1 Million
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $15.6 Million - $21.2 Million	409,961 New	409,961 $17.9 Million
Q4 2019 Feb 14, 2020	SELL	$44.25 - $50.86 $2.97 Million - $3.42 Million	-67,200 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $2.15 Million - $2.49 Million	-53,414 Reduced 44.29%	67,200 $3.11 Million
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $4.88 Million - $5.34 Million	120,614 New	120,614 $5.22 Million
Q1 2019 May 15, 2019	SELL	$40.83 - $45.43 $3.32 Million - $3.7 Million	-81,401 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.48 - $45.59 $2.15 Million - $2.36 Million	-51,844 Reduced 38.91%	81,401 $3.53 Million
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $5.33 Million - $5.97 Million	133,245 New	133,245 $5.95 Million

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.